Current safety issues with quadrivalent meningococcal conjugate vaccines
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae. The main prevention strategy for invasive meningococcal disease in the United States is the routine vaccination of adolescents and other persons at...
Saved in:
Main Authors: | Tanya R. Myers (Author), Michael M. McNeil (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023) -
An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine
by: Pavitra Keshavan, et al.
Published: (2018) -
Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review
by: Tracy a Becerra-Culqui, et al.
Published: (2021) -
Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
by: Sara Viksmoen Watle, et al.
Published: (2021) -
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial
by: Markus Knuf, et al.
Published: (2022)